Literature DB >> 17761658

Spinal muscular atrophy genetic counseling access and genetic knowledge: parents' perspectives.

Candice Meldrum1, Charles Scott, Kathryn J Swoboda.   

Abstract

Spinal muscular atrophy is characterized by degeneration of alpha motor neurons in the anterior horns of the spinal cord, which leads to progressive symmetrical muscle weakness and atrophy. Spinal muscular atrophy is the leading fatal autosomal recessive disorder in infancy, and genetic counseling is an essential component of the care of families of these patients. However, little guidance is available in the published literature regarding the process and benefit of genetic counseling for families. Accordingly, the authors designed a questionnaire to assess parents' knowledge of the disease, gauge their access to genetic counseling, and determine how parents use information gained from counseling to guide choices for future pregnancies. The questionnaire specifically targeted when genetic counseling was received, from whom, parental knowledge regarding spinal muscular atrophy genetics, parental choices regarding spinal muscular atrophy and their child, frequency of prenatal testing, perceived relevance of newborn screening, and opinions regarding the disease. Most families clearly received some type of genetic counseling. Yet how and from whom they received the information varied greatly, as did their genetic knowledge of spinal muscular atrophy. The highest percentage of families received counseling from neurologists, who may not be appropriately prepared to provide formal genetic counseling. Many respondents reported having a negative experience with genetic counseling, possibly because it occurred at the time of diagnosis or shortly afterward, a period of great emotional turmoil. These data suggest that a consistent approach for facilitating how and when genetic counseling is received is greatly needed.

Entities:  

Mesh:

Year:  2007        PMID: 17761658      PMCID: PMC3260047          DOI: 10.1177/0883073807305672

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  11 in total

Review 1.  The neurobiology of childhood spinal muscular atrophy.

Authors:  T O Crawford; C A Pardo
Journal:  Neurobiol Dis       Date:  1996-04       Impact factor: 5.996

2.  A collaborative study on the natural history of childhood and juvenile onset proximal spinal muscular atrophy (type II and III SMA): 569 patients.

Authors:  K Zerres; S Rudnik-Schöneborn; E Forrest; A Lusakowska; J Borkowska; I Hausmanowa-Petrusewicz
Journal:  J Neurol Sci       Date:  1997-02-27       Impact factor: 3.181

3.  Mildly affected patients with spinal muscular atrophy are partially protected by an increased SMN2 copy number.

Authors:  B Wirth; L Brichta; B Schrank; H Lochmüller; S Blick; A Baasner; R Heller
Journal:  Hum Genet       Date:  2006-03-01       Impact factor: 4.132

Review 4.  Genetic testing and risk assessment for spinal muscular atrophy (SMA).

Authors:  Shuji Ogino; Robert B Wilson
Journal:  Hum Genet       Date:  2002-10-03       Impact factor: 4.132

5.  Natural history of denervation in SMA: relation to age, SMN2 copy number, and function.

Authors:  Kathryn J Swoboda; Thomas W Prior; Charles B Scott; Teresa P McNaught; Mark C Wride; Sandra P Reyna; Mark B Bromberg
Journal:  Ann Neurol       Date:  2005-05       Impact factor: 10.422

6.  Incidence, prevalence, and gene frequency studies of chronic childhood spinal muscular atrophy.

Authors:  J Pearn
Journal:  J Med Genet       Date:  1978-12       Impact factor: 6.318

7.  Structure and organization of the human survival motor neurone (SMN) gene.

Authors:  L Bürglen; S Lefebvre; O Clermont; P Burlet; L Viollet; C Cruaud; A Munnich; J Melki
Journal:  Genomics       Date:  1996-03-15       Impact factor: 5.736

8.  Identification and characterization of a spinal muscular atrophy-determining gene.

Authors:  S Lefebvre; L Bürglen; S Reboullet; O Clermont; P Burlet; L Viollet; B Benichou; C Cruaud; P Millasseau; M Zeviani
Journal:  Cell       Date:  1995-01-13       Impact factor: 41.582

9.  Evidence for a modifying pathway in SMA discordant families: reduced SMN level decreases the amount of its interacting partners and Htra2-beta1.

Authors:  Claudia Helmken; Yvonne Hofmann; Frank Schoenen; Gabriela Oprea; Heidrun Raschke; Sabine Rudnik-Schöneborn; Klaus Zerres; Brunhilde Wirth
Journal:  Hum Genet       Date:  2003-10-01       Impact factor: 4.132

10.  Survival motor neuron gene transcript analysis in muscles from spinal muscular atrophy patients.

Authors:  M Gennarelli; M Lucarelli; F Capon; A Pizzuti; L Merlini; C Angelini; G Novelli; B Dallapiccola
Journal:  Biochem Biophys Res Commun       Date:  1995-08-04       Impact factor: 3.575

View more
  8 in total

1.  Reproductive patterns among mothers of males diagnosed with Duchenne or Becker muscular dystrophy.

Authors:  Sarah K Nabukera; Paul A Romitti; Kristin M Caspers; Natalie Street; Christopher Cunniff; Katherine D Mathews; Deborah J Fox; Soman Puzhankara; Emma Ciafaloni; Katherine A James; Yin Su
Journal:  Am J Med Genet A       Date:  2012-12-13       Impact factor: 2.802

2.  "They Just Want to Know" - Genetic Health Professionals' Beliefs About Why Parents Want to Know their Child's Carrier Status.

Authors:  Danya F Vears; Clare Delany; John Massie; Lynn Gillam
Journal:  J Genet Couns       Date:  2017-02-04       Impact factor: 2.537

3.  Genetic Information-Seeking Behaviors and Knowledge among Family Members and Patients with Inherited Bone Marrow Failure Syndromes.

Authors:  Jada G Hamilton; Sadie P Hutson; Amy E Frohnmayer; Paul K J Han; June A Peters; Ann G Carr; Blanche P Alter
Journal:  J Genet Couns       Date:  2014-12-27       Impact factor: 2.537

Review 4.  SMN-inducing compounds for the treatment of spinal muscular atrophy.

Authors:  Monique A Lorson; Christian L Lorson
Journal:  Future Med Chem       Date:  2012-10       Impact factor: 3.808

5.  Carrier testing in children: exploration of genetic health professionals' practices in Australia.

Authors:  Danya F Vears; Clare Delany; Lynn Gillam
Journal:  Genet Med       Date:  2014-09-18       Impact factor: 8.822

6.  A qualitative study of perceptions of meaningful change in spinal muscular atrophy.

Authors:  Sarah McGraw; Ying Qian; Jeff Henne; Jill Jarecki; Kenneth Hobby; Wei-Shi Yeh
Journal:  BMC Neurol       Date:  2017-04-04       Impact factor: 2.474

7.  Understanding the experiences and needs of individuals with Spinal Muscular Atrophy and their parents: a qualitative study.

Authors:  Ying Qian; Sarah McGraw; Jeff Henne; Jill Jarecki; Kenneth Hobby; Wei-Shi Yeh
Journal:  BMC Neurol       Date:  2015-10-24       Impact factor: 2.474

8.  Identification of Novel Microsatellite Markers Flanking the SMN1 and SMN2 Duplicated Region and Inclusion Into a Single-Tube Tridecaplex Panel for Haplotype-Based Preimplantation Genetic Testing of Spinal Muscular Atrophy.

Authors:  Mingjue Zhao; Mulias Lian; Felicia S H Cheah; Arnold S C Tan; Anupriya Agarwal; Samuel S Chong
Journal:  Front Genet       Date:  2019-11-06       Impact factor: 4.599

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.